This map shows the geographic impact of Desnick Rj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desnick Rj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desnick Rj more than expected).
This network shows the impact of papers produced by Desnick Rj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desnick Rj. The network helps show where Desnick Rj may publish in the future.
Co-authorship network of co-authors of Desnick Rj
This figure shows the co-authorship network connecting the top 25 collaborators of Desnick Rj.
A scholar is included among the top collaborators of Desnick Rj based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Desnick Rj. Desnick Rj is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sakuraba, Hitoshi, et al.. (1990). [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease].. PubMed. 22(3). 247–52.
5.
Kornreich, Ruth, et al.. (1989). The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease.. PubMed. 102. 30–43.23 indexed citations
6.
Rj, Desnick, et al.. (1986). Comparison of enzymatic activity with evidence of engraftment in patients with inborn errors of metabolism receiving allogeneic marrow transplantation.. PubMed. 22(1). 135–52.4 indexed citations
7.
Rj, Desnick, et al.. (1983). Inherited metabolic diseases: advances in delineation, diagnosis, and treatment.. PubMed. 19(5). 39–71.1 indexed citations
8.
Rj, Desnick, et al.. (1982). Assays of the heme biosynthetic enzymes. Preface.. PubMed. 28(2-3). 91–3.7 indexed citations
9.
Rj, Desnick. (1982). Gaucher disease: a century of delineation and understanding.. PubMed. 95. 1–30.18 indexed citations
10.
Gatt, S, Tama Dinur, & Desnick Rj. (1982). Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.. PubMed. 95. 315–31.3 indexed citations
11.
Beighton, Peter, et al.. (1982). Genetic heterogeneity in type I Gaucher disease.. PubMed. 95. 495–510.2 indexed citations
12.
Rj, Desnick, et al.. (1980). Feline models of mucopolysaccharidosis.. PubMed. 16(1). 219–24.4 indexed citations
13.
Rj, Desnick, et al.. (1980). Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.. PubMed. 16(1). 393–413.13 indexed citations
14.
Rj, Desnick, et al.. (1980). Immunologic aspects of enzyme replacement therapy. An evaluation of the immune response to unentrapped, erythrocyte- and liposome-entrapped enzyme in C3H/HeJ Gush mice.. PubMed. 16(1). 163–78.2 indexed citations
15.
Rj, Desnick, et al.. (1978). Clinical and experimental transplantation in enzymatic deficiency disease.. PubMed. 146(6). 975–82.2 indexed citations
16.
Krivit, William, et al.. (1973). Enzyme replacement in genetic disease. Prospectus.. PubMed. 9(2). 232–3.1 indexed citations
17.
Rj, Desnick, Maitreyi Raman, Simmons Rl, et al.. (1972). Enzyme therapy in Fabry's disease by renal transplantation.. PubMed. 2. 27–35.1 indexed citations
18.
Rj, Desnick, et al.. (1972). The liver in inherited metabolic diseases of childhood.. PubMed. 4. 463–88.6 indexed citations
19.
Rj, Desnick, et al.. (1971). Further observations on the role of the adenyl cyclase-cyclic AMP (CAMP) system in human lipolysis.. PubMed. 78(6). 989–90.13 indexed citations
20.
Krivit, William, et al.. (1970). Recent advances in Fabry's disease.. PubMed. 83. 121–32.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.